Zoonotic Disease Treatment Market Size & Share Analysis - Growth, Trends & Forecasts (2024 - 2029)

Zoonotic Disease Treatment Market Analysis

The Zoonotic Disease Treatment Market size is estimated at USD 33.40 billion in 2024, and is expected to reach USD 44.40 billion by 2029, growing at a CAGR of 5.90% during the forecast period (2024-2029).

Factors such as the increasing incidence of zoonotic diseases, increased demand for animal proteins/ consumption of animals, and increasing investment in research and development activities are expected to drive the market's growth over the forecast period.

The market for zoonotic disease treatments is expanding, driven by the rising incidence of diseases like rabies, malaria, and avian influenza. For example, a June 2023 report from Frontiers in Microbiology highlighted that zoonotic diseases impact over 2.5 billion humans globally each year. Zoonoses, transmitted from vertebrate animals to humans, account for over 60% of recognized human diseases and 75% of emerging infectious diseases.

Moreover, the emergence of zoonotic diseases like the Ebola outbreak in Africa has underscored the urgency for effective treatments and vaccines. In September 2022, Uganda declared an Ebola disease outbreak in the country. It was the country’s first Sudan ebolavirus outbreak in a decade. In total, during this outbreak, there were 164 cases (142 confirmed and twenty-two probable), fifty-five confirmed deaths, and eighty-seven recovered patients.

Additionally, the rise in research and developmental activities in the zoonotic diseases market is also boosting its growth. For instance, in August 2023, Merck announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for ERVEBO, which is indicated for preventing disease caused by Zaire ebolavirus in individuals 12 months of age and older.

Therefore, owing to the factors mentioned above, such as the increasing incidence of zoonotic diseases and the rise in research and developmental activities, are expected to drive the growth of the zoonotic disease treatment market.

However, a lack of awareness about the spread of zoonotic diseases in the general population is restraining the growth of the market.

Zoonotic Disease Treatment Market Trends

Malaria Segment is Expected to Witness a Significant Growth Over the Forecast Period

Zoonotic Disease Treatment Industry Segmentation

As per the scope of the report, zoonotic disease treatment refers to medical interventions, therapies, and medications used to diagnose, manage, and cure diseases that can be transmitted from animals to humans. These diseases are caused by pathogens such as nematodes, ticks, rodents, viruses, bacteria, fungi, and parasites that can jump between animal species and humans, leading to zoonotic infections. The zoonotic disease treatment market is segmented by disease type, connective cause, route of administration, end users and geography. The disease type segment is further divided into rabies, hepatitis, tuberculosis, leishmaniasis, Ebola virus, malaria, and others. The connective cause segment is further segmented into nematode, ticks, rodents, virus, bacteria, and others. The Route of Administration segment is further bifurcated into oral administration, intramuscular injections, intravenous administration, and topical administration. The end user segment is further divided into hospitals, specialty clinics, home care, and others. The geography segment is further bifurcated into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers the value (in USD) for the above segments.